Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials

被引:0
|
作者
Chris J Bushe
Nicola C Savill
机构
[1] Lilly House,Eli Lilly and Company Ltd
关键词
ADHD; Suicide-related events; Summary of product characteristics; Systematic review; Atomoxetine; Methylphenidate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Switch in Therapy from Methylphenidate to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Analysis of Patient Records
    Warrer, Pernille
    Thomsen, Per Hove
    Dalsgaard, Soren
    Hansen, Ebba Holme
    Aagaard, Lise
    Kildemoes, Helle Wallach
    Rasmussen, Henrik Berg
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (04) : 354 - 361
  • [22] Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder
    Park, Jeong Ha
    Lee, Young Sik
    Sohn, Ji Hyun
    Han, Doug Hyun
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (06) : 427 - 432
  • [23] Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression
    Cunill, Ruth
    Castells, Xavier
    Tobias, Aurelio
    Capella, Dolors
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (09) : 961 - 969
  • [24] The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials
    Ravishankar, Vinutha
    Chowdappa, Suresh Vedaveni
    Benegal, Vivek
    Muralidharan, Kesavan
    ASIAN JOURNAL OF PSYCHIATRY, 2016, 24 : 53 - 58
  • [25] Efficacy of atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder
    Dunn, D
    Allen, A
    Thomason, C
    Zhang, S
    Michelson, D
    Kelsey, D
    ANNALS OF NEUROLOGY, 2003, 54 : S143 - S143
  • [26] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    Garnock-Jones, Karly P.
    Keating, Gillian M.
    CNS DRUGS, 2010, 24 (01) : 85 - 88
  • [27] An Individual Participant Data Meta-analysis: Behavioral Treatments for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Groenman, Annabeth P.
    Hornstra, Rianne
    Hoekstra, Pieter J.
    Steenhuis, Laura
    Aghebati, Asma
    Boyer, Bianca E.
    Buitelaar, Jan K.
    Chronis-Tuscano, Andrea
    Daley, David
    Dehkordian, Parisa
    Dvorsky, Melissa
    Franke, Nike
    DuPaul, George J.
    Gershy, Naama
    Harvey, Elizabeth
    Hennig, Timo
    Herbert, Sharonne
    Langberg, Joshua
    Mautone, Jennifer A.
    Mikami, Amori Yee
    Pfiffner, Linda J.
    Power, Thomas J.
    Reijneveld, Sijmen A.
    Schramm, Satyam Antonio
    Schweitzer, Julie B.
    Sibley, Margaret H.
    Sonuga-Barke, Edmund
    Thompson, Catharine
    Thompson, Margaret
    Webster-Stratton, Carolyn
    Xie, Yuhuan
    Luman, Marjolein
    van der Oord, Saskia
    van den Hoofdakker, Barbara J.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (02): : 144 - 158
  • [28] Cardiovascular Measures in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Who Are New Users of Methylphenidate and Atomoxetine
    Arcieri, Romano
    Germinario, Elena A. P.
    Bonati, Maurizio
    Masi, Gabriele
    Zuddas, Alessandro
    Vella, Stefano
    Chiarotti, Flavia
    Panei, Pietro
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (06) : 423 - 431
  • [29] Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression
    Schwartz, Shimon
    Correll, Christoph U.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (02): : 174 - 187
  • [30] Treatment Related Adverse Events In Children With Attention-Deficit/Hyperactivity Disorder Using Atomoxetine
    Kasar, Nurdan
    Yektas, Cigdem
    Tufan, Ali Evren
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2021, 11 (04): : 243 - 248